Citadel Advisors’s Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant NFYS.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,347
Closed -$101K 15608
2022
Q3
$101K Buy
+10,347
New +$101K ﹤0.01% 11088

Other funds holding NFYS.U

Citadel Advisors's NFYS.U Position: Q4 2022 in Review

Citadel Advisors sold out of Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (NFYS.U) in Q4 2022, closing a stake of 10,347 shares — an estimated $101K sold.

Citadel Advisors first reported a position in NFYS.U in Q3 2022 and held it in 1 quarter. The position peaked at $101K in Q3 2022. 6 funds tracked by Wall St. Rank hold NFYS.U as of Q4 2022.

  • Citadel Advisors reported no remaining Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 10,347 Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q4 2022, an estimated $101K.
  • Citadel Advisors first reported a position in Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q3 2022 and held it in 1 quarter.
  • Citadel Advisors's Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $101K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.